Fexofenadine as Adjuvant Therapy in Parkinson Disease

NCT06785298 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Levodopa/carbidopa
DRUG: Fexofenadine

Sponsor

Tanta University